9-Hydroxyellipticine and Derivatives as Chemotherapy Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
67-76
Author(s):
Margaret M. Harding and Annaleise R. Grummitt
Epothilone B and its Analogs - A New Family of Anticancer Agents
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
3
Page:
149-158
Author(s):
Karl-Heinz Altmann
Vascular Endothelial Cell Growth Factor (VEGF), An Emerging Target for Cancer Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
95-117
Author(s):
S. Shinkaruk, M. Bayle, G. Lain and G. Deleris
New Approach to Cancer Therapy: The Application of Signal Transduction to Anti-Cancer Drug
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
119-131
Author(s):
Shinji Osada and Shigetoyo Saji
Cardiac Toxicity of Antineoplastic Anthracyclines
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
3
Page:
151-171
Author(s):
Riccardo Zucchi and Romano Danesi
Antivirals at the Mirror: The Lack of Stereospecificity of Some Viral and Human Enzymes Offers Novel Opportunities in Antiviral Drug Development
Journal:
Current Drug Targets - Infectious Disorders
Volume:
3
Page:
41-53
Author(s):
Federico Focher, Silvio Spadari and Giovanni Maga
Viral and Cellular Cytokines as Therapeutic Targets in AIDS-Related Lymphoproliferative Disorders
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
3
Page:
81-96
Author(s):
Yoshiyasu Aoki and Giovanna Tosato
Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis
Journal:
Current Drug Targets
Volume:
4
Page:
123-131
Author(s):
C. Chandra Kumar
Current Targets for Anticancer Drug Discovery
Journal:
Current Drug Targets
Volume:
4
Page:
159-179
Author(s):
Nguyen-Hai Nam and Keykavous Parang
Neuropeptides as Autocrine Growth Factors in Cancer Cells
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
495-509
Author(s):
Terry W. Moody, Daniel Chan, Jan Fahrenkrug and Robert T. Jensen